The mechanism of mammalian proton-coupled peptide transporters

• Published in: eLife 2024-07, Vol.13
• Main Authors: Lichtinger, Simon M, Parker, Joanne L, Newstead, Simon, Biggin, Philip C
• Format: Article
• Language: English
• Subjects: Active transport; Animals; Bioavailability; Biological Transport; computational; Drug development; Free energy; Humans; Mammals - metabolism; Membrane Transport Proteins - chemistry; Membrane Transport Proteins - metabolism; Molecular dynamics; Molecular Dynamics Simulation; Peptides; Phylogeny; Protein Conformation; protonation; Protons; Simulation; solute carrier protein; Structural Biology and Molecular Biophysics; Thermodynamics
• ISSN: 2050-084X; 2050-084X
• DOI: 10.7554/eLife.96507

Proton-coupled oligopeptide transporters (POTs) are of great pharmaceutical interest owing to their promiscuous substrate binding site that has been linked to improved oral bioavailability of several classes of drugs. Members of the POT family are conserved across all phylogenetic kingdoms and function by coupling peptide uptake to the proton electrochemical gradient. Cryo-EM structures and alphafold models have recently provided new insights into different conformational states of two mammalian POTs, SLC15A1, and SLC15A2. Nevertheless, these studies leave open important questions regarding the mechanism of proton and substrate coupling, while simultaneously providing a unique opportunity to investigate these processes using molecular dynamics (MD) simulations. Here, we employ extensive unbiased and enhanced-sampling MD to map out the full SLC15A2 conformational cycle and its thermodynamic driving forces. By computing conformational free energy landscapes in different protonation states and in the absence or presence of peptide substrate, we identify a likely sequence of intermediate protonation steps that drive inward-directed alternating access. These simulations identify key differences in the extracellular gate between mammalian and bacterial POTs, which we validate experimentally in cell-based transport assays. Our results from constant-PH MD and absolute binding free energy (ABFE) calculations also establish a mechanistic link between proton binding and peptide recognition, revealing key details underpining secondary active transport in POTs. This study provides a vital step forward in understanding proton-coupled peptide and drug transport in mammals and pave the way to integrate knowledge of solute carrier structural biology with enhanced drug design to target tissue and organ bioavailability.